Acuta Capital Partners as of Sept. 30, 2022
Portfolio Holdings for Acuta Capital Partners
Acuta Capital Partners holds 46 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Apellis Pharmaceuticals (APLS) | 16.3 | $38M | 554k | 68.30 | |
| Aadi Bioscience (AADI) | 11.3 | $26M | 1.8M | 14.13 | |
| Relmada Therapeutics (RLMD) | 9.0 | $21M | 566k | 37.02 | |
| Bellus Health Com New | 6.5 | $15M | 1.4M | 10.56 | |
| Iveric Bio | 4.4 | $10M | 564k | 17.94 | |
| Xenon Pharmaceuticals (XENE) | 4.2 | $9.8M | 273k | 36.10 | |
| Bcls Acquisition Corp- Cl A Com Cl A | 3.6 | $8.4M | 843k | 10.02 | |
| Syndax Pharmaceuticals (SNDX) | 3.4 | $7.8M | 325k | 24.03 | |
| Celldex Therapeutics Com New (CLDX) | 3.2 | $7.5M | 267k | 28.11 | |
| Miragen Therapeutics (VRDN) | 3.2 | $7.4M | 363k | 20.51 | |
| Kura Oncology (KURA) | 3.2 | $7.3M | 537k | 13.66 | |
| Mirati Therapeutics | 3.2 | $7.3M | 105k | 69.84 | |
| Ventyx Biosciences (VTYX) | 2.7 | $6.3M | 180k | 34.91 | |
| United Therapeutics Corporation (UTHR) | 2.5 | $5.8M | 28k | 209.38 | |
| Jiya Acquisition Corp -cl A Com Cl A | 2.4 | $5.6M | 563k | 9.97 | |
| Milestone Pharmaceuticals (MIST) | 2.4 | $5.5M | 597k | 9.19 | |
| Sarepta Therapeutics (SRPT) | 2.0 | $4.6M | 42k | 110.53 | |
| Bioatla (BCAB) | 1.7 | $4.0M | 520k | 7.70 | |
| Gossamer Bio (GOSS) | 1.5 | $3.4M | 285k | 11.98 | |
| Amicus Therapeutics (FOLD) | 1.3 | $3.0M | 290k | 10.44 | |
| Arrowhead Pharmaceuticals (ARWR) | 1.2 | $2.9M | 88k | 33.05 | |
| Gh Research Ordinary Shares (GHRS) | 1.2 | $2.8M | 243k | 11.62 | |
| Aclaris Therapeutics (ACRS) | 1.1 | $2.5M | 161k | 15.74 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 1.0 | $2.4M | 303k | 7.91 | |
| Terns Pharmaceuticals (TERN) | 0.9 | $2.1M | 351k | 5.89 | |
| Vaxcyte (PCVX) | 0.9 | $2.0M | 85k | 24.00 | |
| Pmv Pharmaceuticals (PMVP) | 0.8 | $1.8M | 155k | 11.90 | |
| Fulcrum Therapeutics (FULC) | 0.8 | $1.8M | 220k | 8.09 | |
| Altimmune Com New (ALT) | 0.7 | $1.6M | 125k | 12.77 | |
| Iovance Biotherapeutics (IOVA) | 0.6 | $1.5M | 154k | 9.58 | |
| Pyxis Oncology Common Stock (PYXS) | 0.6 | $1.3M | 669k | 1.97 | |
| Merus N V (MRUS) | 0.5 | $1.2M | 59k | 20.03 | |
| Allakos (ALLK) | 0.5 | $1.2M | 193k | 6.12 | |
| Rezolute Com New (RZLT) | 0.5 | $1.1M | 419k | 2.74 | |
| ImmunoGen | 0.3 | $669k | 140k | 4.78 | |
| Horizon Therapeutics SHS | 0.1 | $248k | 4.0k | 62.00 | |
| Esperion Therapeutics (ESPR) | 0.1 | $201k | 30k | 6.70 | |
| Ideaya Biosciences (IDYA) | 0.1 | $149k | 10k | 14.90 | |
| Springworks Therapeutics (SWTX) | 0.1 | $143k | 5.0k | 28.60 | |
| Dice Therapeutics | 0.1 | $136k | 6.7k | 20.30 | |
| Zentalis Pharmaceuticals (ZNTL) | 0.0 | $108k | 5.0k | 21.60 | |
| Ngm Biopharmaceuticals (NGM) | 0.0 | $98k | 7.5k | 13.07 | |
| Kinnate Biopharma (KNTE) | 0.0 | $60k | 5.0k | 12.00 | |
| Trevi Therapeutics (TRVI) | 0.0 | $56k | 36k | 1.54 | |
| Nuvation Bio *w Exp 07/07/2027 (NUVB.WS) | 0.0 | $15k | 91k | 0.17 | |
| Biomea Fusion (BMEA) | 0.0 | $10k | 1.0k | 10.00 |
